< Return to Search Results

Drug Details

Drug Number:	603/10
Drug Name:	saxagliptin (Onglyza)
Drug Manufacturer:	Bristol-Myers Squibb Pharmaceuticals
BNF Category:	Endocrine system
Submission type :	Full submission
Date Advice Issued:	08.03.10
Indication:	Type 2 diabetes

Drug Advice

saxagliptin (Onglyza)

Press Statement

Read the press statement

Read the briefing note

Minutes

Read the minutes

Notes

< Return to Search Results

Other SMC Advice for this Drug

There is currently no other SMC advice for this product

SEARCH FOR A DRUG

UNKNOWN - All BNF Categories - AnaesthesiaCardiovascular systemCentral nervous systemEar, nose and oropharynxEndocrine systemEyeGastro-intestinal systemImmunological products and vaccinesInfectionsMalignant disease and immunosuppressionMusculoskeletal and joint diseasesNutrition and bloodObstetrics, gynaecology, and urinary-tract disordersRespiratory systemSkin

UNKNOWN - All Types of Submission - Abbreviated SubmissionFull submissionIRPNon submissionResubmission

Help on how to improve your search.